Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
25/09/2025
On Wednesday, the South Korean won finally fell by 0.74% against the US dollar, closing at 1404.66 won, continuing to gently oscillate downwards throughout the day.
Latest
5 m ago
ABC Entertainment Channel: "Jimmy Kimmel Live" returned on Tuesday, with a total viewership of 6.26 million on both television and radio platforms.
14 m ago
Insiders say that Rwanda and Congo aim to complete the relevant measures by the end of the year. Actions against the Democratic Forces for the Liberation of Rwanda and the lifting of Rwandan defensive measures will begin at the end of October.
18 m ago
A small plane crashed in Venezuela and two people were rescued.
18 m ago
Boston - (U.S. Business Information) - September 24, 2025 - PepGen Inc. (NASDAQ: PEPG) is a clinical-stage biotechnology company developing next-generation oligonucleotide therapies aimed at changing the treatment of severe neuromuscular and neurological diseases. The company announced today positive clinical data from the 15 mg/kg dose cohort of the ongoing FREEDOM-DM1 Phase 1 Single Ascending Dose (SAD) study in patients with myotonic dystrophy (DM1). These latest results show that the average splicing correction rate after a single dose of 15 mg/kg of PGN-EDODM1 is 53.7%, significantly higher than previously reported splicing correction in DM1 patients.
24 m ago
Air Canada: The financial impact caused by the labor dispute is expected to reduce operating income and adjusted earnings before interest, taxes, depreciation, and amortization by $375 million.
See all latest